Drug
Ciprofloxacin Dispersion For Inhalation
Ciprofloxacin Dispersion For Inhalation: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ciprofloxacin dispersion for inhalation NCT02104245 | Phase 3 | Non Cystic Fibrosis Bronchiectasis |
Latest
No recent events.
Follow Ciprofloxacin Dispersion For Inhalation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.